Evidence map›Paper›PMID 34746107›Full record

ArticleFrontiers in bioengineering and biotechnology2021

Fabrication of Antimicrobial Multilayered Nanofibrous Scaffolds-Loaded Drug

Qi Liu, Hengmin Jia, Wenchong Ouyang, Yan Mu, Zhengwei Wu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Qi LiuSchool of Nuclear Science and Technology, University of Science and Technology of China, Hefei, China.
Hengmin JiaDepartment of Infection Control and Prevention, The First Affiliated Hospital of University of Science and Technology of China, Hefei, China.
Wenchong OuyangSchool of Nuclear Science and Technology, University of Science and Technology of China, Hefei, China.
Yan MuDepartment of Infection Control and Prevention, The First Affiliated Hospital of University of Science and Technology of China, Hefei, China.
Zhengwei WuSchool of Nuclear Science and Technology, University of Science and Technology of China, Hefei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanofibers prepared by biobased materials are widely used in the field of biomedicine, owing to outstanding biocompatibility, biodegradable characters, and excellent mechanical behavior. Herein, we fabricated multilayered nanofibrous scaffolds in order to improve the performance of drug delivery. The composite layer-by-layer scaffolds were incorporated by hydrophobic poly(l-lactic acid) (PLA): polycaprolactone (PCL) and hydrophilic poly(vinyl alcohol) (PVA) nanofibers

Indexed as

antimicrobialbiodegradabledrug deliverymultilayered nanofiberspoly(vinyl alcohol)

Identifiers

PMID34746107
PMCPMC8565619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.